Thursday, 02 April 2020 08:20

CSIRO scientists start testing potential vaccines for COVID-19 Featured

The CSIRO is testing the COVID-19 vaccine candidates for efficacy. The CSIRO is testing the COVID-19 vaccine candidates for efficacy. Courtesy CSIRO

Australia's national science agency, the CSIRO, says it has begun the first stage of testing potential vaccines for COVID-19, with the testing process expected to take three months.

The organisation said work was progressing at its high-containment biosecurity facility, the Australian Animal Health Laboratory which is situated in Geelong, about 100km from Melbourne.

A statekent from the CSIRO said had been engaged by the Coalition for Epidemic Preparedness in January to start working on the vaccine. The CSIRO and CEPI became partners last year.

The CEPI, working in co-ordination with the World Health Organisation, has identified vaccine candidates from the University of Oxford in the UK and Inovio Pharmaceuticals in the US to be the first to undergo pre=clinical trials at the CSIRO's Geelong facility.

The CSIRO said this work was part of its growing involvement in trying to find a means to tackle COVID-19; it included scaling up other likely vaccine candidates at a production facility in Melbourne.

csiro vaccine

Scientists starting to test vaccines for COVID-19 at CSIRO's Australian Animal Health Laboratory. Courtesy CSIRO

CSIRO chief executive Dr Larry Marshall said: “Beginning vaccine candidate testing at CSIRO is a critical milestone in the fight against COVID-19, made possible by collaboration both within Australia and across the globe.

“CSIRO researchers are working around-the-clock to combat this disease which is affecting so many. Whether it’s at the Australian Animal Health Laboratory or at our state-of-the-art biologics manufacturing facility, we will keep working until this viral enemy is defeated.”.

Apart from the testing of the vaccines for their effectiveness, the CSIRO said it was also looking at the best way of administering them, whether through an intra-muscular injection or as a nasal spray.

AAHL director Professor Trevor Drew, who is leading CSIRO’s COVID-19 virus and vaccine work, said: “We have been studying SARS CoV-2 since January and getting ready to test the first vaccine candidates as soon as they are available.

"We are carefully balancing operating at speed with the critical need for safety in response to this global public health emergency.”

The AAHL is the only high biocontainment facility in the southern hemisphere and its scientists work with highly dangerous and exotic pathogens, including diseases that transfer from animals to people.

Dr Marshall added: “Tackling disease and supporting better health outcomes takes a one-health approach.

“In 2016, CSIRO created the Health and Biosecurity research group who work with our scientists at AAHL to tackle our national and international health and biosecurity challenges together, so we can better protect the health of our people, environment, agriculture and industries and our way of life.

“This, combined with our data science and manufacturing capability in our biological production facility, means we were well prepared to help Australia in One Health with disease identification, prevention and management, to deliver the real world solutions that our nation expects from science.”

WEBINAR event: IT Alerting Best Practices 27 MAY 2PM AEST

LogicMonitor, the cloud-based IT infrastructure monitoring and intelligence platform, is hosting an online event at 2PM on May 27th aimed at educating IT administrators, managers and leaders about IT and network alerts.

This free webinar will share best practices for setting network alerts, negating alert fatigue, optimising an alerting strategy and proactive monitoring.

The event will start at 2pm AEST. Topics will include:

- Setting alert routing and thresholds

- Avoiding alert and email overload

- Learning from missed alerts

- Managing downtime effectively

The webinar will run for approximately one hour. Recordings will be made available to anyone who registers but cannot make the live event.



Security requirements such as confidentiality, integrity and authentication have become mandatory in most industries.

Data encryption methods previously used only by military and intelligence services have become common practice in all data transfer networks across all platforms, in all industries where information is sensitive and vital (financial and government institutions, critical infrastructure, data centres, and service providers).

Get the full details on Layer-1 encryption solutions straight from PacketLight’s optical networks experts.

This white paper titled, “When 1% of the Light Equals 100% of the Information” is a must read for anyone within the fiber optics, cybersecurity or related industry sectors.

To access click Download here.


Sam Varghese

website statistics

Sam Varghese has been writing for iTWire since 2006, a year after the site came into existence. For nearly a decade thereafter, he wrote mostly about free and open source software, based on his own use of this genre of software. Since May 2016, he has been writing across many areas of technology. He has been a journalist for nearly 40 years in India (Indian Express and Deccan Herald), the UAE (Khaleej Times) and Australia (Daily Commercial News (now defunct) and The Age). His personal blog is titled Irregular Expression.



Recent Comments